Etravirine TMC-125 CAS 269055-15-4 Assay ≥99.0% (HPLC) API Factory High Purity

Inkcazelo emfutshane:

Igama leMichiza: I-Etravirine (TMC-125)

CAS: 269055-15-4

Imbonakalo: Umgubo oqinileyo oMhlophe

Uvavanyo: ≥99.0% (HPLC)

I-Etravirine yi-non-nucleoside reverse transcriptase inhibitor (NNRTI) esetyenziselwa unyango lwe-HIV.

Umgangatho ophezulu we-API, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Umenzi onobunyulu obuPhezulu kunye noMgangatho oZinzile
Igama leKhemikhali: Etravirine (TMC-125)
CAS: 269055-15-4
Umgangatho ophezulu we-API, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	Etravirine
Izithethantonye	TMC-125
Inombolo yeCAS	269055-15-4
Inombolo yeCAT	RF-API54
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C20H15BrN6O
Ubunzima beMolekyuli	435.28
Ukuxinana	1.439 g/cm3
Imeko yokuthumela ngenqanawa	Phantsi koBubushushu be-Ambient
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oqinileyo oMhlophe
Ukuchongwa	Ngo-IR, HPLC
Indawo yokunyibilika	211.0 ~ 216.0℃
Isiqulatho samanzi	≤0.50%
Intsalela kwi-Ignition	≤0.20%
Iintsimbi ezinzima	≤20ppm
Nakuphi na Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤1.0%
Isivavanyi	≥99.0% (HPLC)
Umgangatho woVavanyo	Umgangatho woShishino

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Etravirine (TMC-125) (CAS 269055-15-4) sisizukulwana sesibini i-non-nucleoside reverse transcriptase inhibitor (NNRTI) esetyenziselwa unyango lwe-HIV.Iboniswa ukuba isetyenziswe ngokudityaniswa nezinye ii-antiretroviral agents ekunyangeni usulelo lwe-HIV-1 kwizigulane ezinamava kunyango ezinobungqina bokuphindaphinda kwentsholongwane egazini kunye ne-HIV-1 exhathisayo kwii-NNRTIs ezikhoyo ngoku kunye nezinye ii-antiretroviral agents.Ii-NNRTIs, kunye ne-nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), ngamalungu abalulekileyo erejimeni ezidityanisiweyo ezisetyenziswa ngoku ukunyanga usulelo lwe-HIV-1.I-NRTIs / NtRTIs yenza ngokukhuphisana ne-nucleotide substrates yendalo ye-reverse transcriptase yokufakwa kwi-DNA yentsholongwane kunye nokupheliswa kwekhonkco elilandelayo.Ngokwahlukileyo, ii-NNRTIs zibophelela kwindawo ye-allosteric ye-enzyme kwaye iphazamise umsebenzi we-DNA polymerase ngokubangela utshintsho oluhambelanayo kwindawo ye-catalytic.